- Home
- SMSI vs GNTA Comparison
SMSI vs GNTA Comparison
Compare SMSI & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMSI | GNTA |
|---|---|---|
| Founded | 1982 | 2014 |
| Country | United States | Italy |
| Employees | N/A | 13 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 19.9M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | SMSI | GNTA |
|---|---|---|
| Price | $3.02 | $1.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 164.2K | ★ 2.1M |
| Earning Date | 04-29-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.94 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,363,000.00 | N/A |
| Revenue This Year | $13.97 | N/A |
| Revenue Next Year | $53.35 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.41 | $0.55 |
| 52 Week High | $6.13 | $10.00 |
Technical Indicators
Market Signals| Indicator | SMSI | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 58.90 | 62.65 |
| Support Level | $0.62 | $1.31 |
| Resistance Level | $6.13 | $2.20 |
| Average True Range (ATR) | 0.44 | 0.32 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 43.15 | 42.35 |
Price Performance
Historical ComparisonAbout SMSI Smith Micro Software Inc.
Smith Micro Software Inc provides software solutions that simplify and enhance the mobile experience to some of the wireless service providers around the globe. The company's solutions include SafePath product suite provides comprehensive and easy-to-use tools to protect family digital lifestyles and manage connected devices both inside and outside the home; CommSuite premium messaging platform helps mobile service providers deliver a next-generation voicemail experience to mobile subscribers, while monetizing a legacy cost-center; and ViewSpot its retail display management platform provided wireless carriers and retailers with a way to bring powerful on-screen, interactive demos to life. It operates in single segment: Wireless.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.